Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.65
+0.02000.76%
Volume:322.07K
Turnover:859.90K
Market Cap:516.75M
PE:-10.45
High:2.73
Open:2.69
Low:2.64
Close:2.63
52wk High:3.11
52wk Low:1.12
Shares:195.00M
Float Shares:163.00M
Volume Ratio:0.83
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2535
EPS(LYR):-0.2325
ROE:-25.96%
ROA:-23.46%
PB:2.46
PE(LYR):-11.40

Loading ...

Ovid Therapeutics Inc. : H.c. Wainwright Raises Target Price to $5 from $4

THOMSON REUTERS
·
5 hours ago

U.S. Research Roundup- Adobe, Chewy, Mosaic

Reuters
·
8 hours ago

Ovid Therapeutics Management Presents at Cantor Global Healthcare Conference Webcast

Reuters
·
Sep 03

Acrivon Therapeutics Names Michaela Levin Chief Business Officer

Reuters
·
Aug 31

Oppenheimer Sticks to Its Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
Aug 14

Wedbush Keeps Their Buy Rating on Ovid Therapeutics (OVID)

TIPRANKS
·
Aug 14

Ovid Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Ovid Therapeutics Releases Corporate Presentation Outlining Neural Hyperexcitability Drug Pipeline

Reuters
·
Aug 13

Ovid Therapeutics Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Ovid Q2 FY26 Net Loss Widens to $15 Million; Operating Expenses Rise to $16.4 Million

Reuters
·
Aug 13

Ovid Therapeutics Q2 Revenue USD 733 Thousand VS. Ibes Estimate USD 0

THOMSON REUTERS
·
Aug 13

Ovid Therapeutics Q2 EPS USD -0.08

THOMSON REUTERS
·
Aug 13

Ovid Therapeutics Inc. Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Ovid Therapeutics CFO Charles Ross Files Initial Beneficial Ownership Statement

Reuters
·
Jul 09

Ovid Therapeutics CFO Jeffrey Rona to step down, Charles Carter to succeed

TIPRANKS
·
Jul 08

Ovid Therapeutics Names Kevin Norrett Chief Business Officer

Reuters
·
Jul 08

Ovid Therapeutics - Promotes Charles Carter to Chief Financial Officer

THOMSON REUTERS
·
Jul 08

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

THOMSON REUTERS
·
Jul 08

Ovid Therapeutics director Anna Greka files initial beneficial ownership statement

Reuters
·
Jun 18

Ovid Therapeutics shareholders approve executive pay advisory proposal at annual meeting

Reuters
·
Jun 11